GLP-1 Weight-Loss Drugs Are Getting Easier to Buy, Thanks to Walmart, Costco and Amazon

Getting a prescription for Wegovy or Zepbound used to mean going through your employer’s health plan. That’s changing fast.

More companies are dropping coverage for GLP-1 drugs, and patients are responding by turning to direct-to-consumer prescription programs instead. Retail giants noticed the shift right away. Walmart, Costco, CVS and Amazon are all racing to become the go-to source for these medications. 

It makes sense when you think about it. A weight-loss drug isn’t a one-time purchase. Patients need refills every single month, and that kind of loyalty is hard to come by in retail.

Amazon has leaned hard into this opportunity. Through Amazon Pharmacy, customers can now get Wegovy, along with some of the newer oral GLP-1 options on the market. Pricing varies depending on insurance. If you’re insured, the cost can start as low as $25 a month. Paying out of pocket costs more, though the company hasn’t shied away from competitive pricing to win customers over. Middleway NutritionMiddleway Nutrition

Amazon isn’t just filling prescriptions either. The company’s One Medical division now runs a weight management program built around ongoing care, not just handing over pills.

Costco took a different route. The warehouse retailer partnered with Sesame, a virtual care marketplace, to offer members a three-month weight-loss program. That program includes access to Ozempic prescriptions, and according to Sesame, the demand has been enormous. Weight loss has actually become the single most searched term among Costco members looking for primary care through the platform. 

That’s a telling sign of just how much interest there is.

Walmart, meanwhile, has positioned its stores as pickup points for prescriptions filled through LillyDirect Self Pay Pharmacy Solutions. The price for Zepbound doses through this program starts around $349. Customers can pick their prescription up in store or simply have it delivered at home. 

Either way, they still have to walk past aisles of merchandise to get there. Retailers know that, and it’s part of the appeal.

Industry analysts have compared the whole setup to loyalty program economics. A monthly prescription refill guarantees a customer walks through your doors, or at least places an order, on a predictable schedule. Few other products in retail can promise that kind of consistency. 

It’s worth stepping back to look at what these drugs actually do. GLP-1 receptor agonists are approved by the FDA for treating type 2 diabetes and, in several cases, chronic obesity management. They work by mimicking a hormone the body already produces naturally, one that helps regulate appetite and blood sugar levels. 

None of these medications are available without a prescription. That’s an important point, especially given how much attention they’re getting online.

The FDA has also issued warnings about compounded versions of these drugs sold outside the traditional pharmacy system. Because those versions skip the agency’s standard review process, there’s no guarantee they’re safe, effective, or even accurately dosed. Patients considering these options should talk to their doctor first, and those interested in ongoing research can check current clinical trials involving these medications. 

There’s a flip side to all this retail competition, too. Smaller, independent pharmacies may struggle to keep up, since they don’t have the scale or delivery networks that companies like Amazon and Walmart can offer. 

For patients, though, more competition generally means more choices and, potentially, lower prices. Just don’t skip the doctor’s visit. Access is expanding, but these are still prescription medications that require medical oversight, not just a trip to the pharmacy counter.